Cargando…

Extensively drug-resistant tuberculosis in India: A review

BACKGROUND & OBJECTIVES: Extensively drug resistant tuberculosis (XDR-TB) has become a new threat for the control of TB in many countries including India. Its prevalence is not known in India as there is no nation-wide surveillance. However, there have been some reports from various hospitals in...

Descripción completa

Detalles Bibliográficos
Autores principales: Michael, Joy Sarojini, John, T. Jacob
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3516027/
https://www.ncbi.nlm.nih.gov/pubmed/23168700
_version_ 1782252264408219648
author Michael, Joy Sarojini
John, T. Jacob
author_facet Michael, Joy Sarojini
John, T. Jacob
author_sort Michael, Joy Sarojini
collection PubMed
description BACKGROUND & OBJECTIVES: Extensively drug resistant tuberculosis (XDR-TB) has become a new threat for the control of TB in many countries including India. Its prevalence is not known in India as there is no nation-wide surveillance. However, there have been some reports from various hospitals in the country. METHODS: We have reviewed the studies/information available in the public domain and found data from 10 tertiary care centres in 9 cities in India. RESULTS: A total of 598 isolates of XDR Mycobacterium tuberculosis have been reported in the studies included. However, the reliability of microbiological methods used in these studies was not checked and thus the XDR-TB data remained invalidated in reference laboratories. INTERPRETATION & CONCLUSIONS: Systematic surveillance and containment interventions are urgently needed.
format Online
Article
Text
id pubmed-3516027
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-35160272012-12-11 Extensively drug-resistant tuberculosis in India: A review Michael, Joy Sarojini John, T. Jacob Indian J Med Res Original Article BACKGROUND & OBJECTIVES: Extensively drug resistant tuberculosis (XDR-TB) has become a new threat for the control of TB in many countries including India. Its prevalence is not known in India as there is no nation-wide surveillance. However, there have been some reports from various hospitals in the country. METHODS: We have reviewed the studies/information available in the public domain and found data from 10 tertiary care centres in 9 cities in India. RESULTS: A total of 598 isolates of XDR Mycobacterium tuberculosis have been reported in the studies included. However, the reliability of microbiological methods used in these studies was not checked and thus the XDR-TB data remained invalidated in reference laboratories. INTERPRETATION & CONCLUSIONS: Systematic surveillance and containment interventions are urgently needed. Medknow Publications & Media Pvt Ltd 2012-10 /pmc/articles/PMC3516027/ /pubmed/23168700 Text en Copyright: © The Indian Journal of Medical Research http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Michael, Joy Sarojini
John, T. Jacob
Extensively drug-resistant tuberculosis in India: A review
title Extensively drug-resistant tuberculosis in India: A review
title_full Extensively drug-resistant tuberculosis in India: A review
title_fullStr Extensively drug-resistant tuberculosis in India: A review
title_full_unstemmed Extensively drug-resistant tuberculosis in India: A review
title_short Extensively drug-resistant tuberculosis in India: A review
title_sort extensively drug-resistant tuberculosis in india: a review
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3516027/
https://www.ncbi.nlm.nih.gov/pubmed/23168700
work_keys_str_mv AT michaeljoysarojini extensivelydrugresistanttuberculosisinindiaareview
AT johntjacob extensivelydrugresistanttuberculosisinindiaareview